Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AZ.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.114SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.190SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.552SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.89SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
M.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.333SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.429SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.463SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.373SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.80SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.433SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.36.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.221.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.449SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.152SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.146SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
D.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.81SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.71SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.445SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.21 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.123SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.143SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.360SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.347SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.195SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.321SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.379SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.78SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.231SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.67SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.190SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.120SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AM.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.249SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.505SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used